Sentien Biotechnologies, Inc.
Biotechnology company · Medford, Massachusetts, United States
Sentien Biotechnologies, Inc. is a biotechnology company headquartered in Medford, Massachusetts, United States. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $10 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2015.
Sentien Biotechnologies at a glance
What does Sentien Biotechnologies do?
US government research funding
7 SBIR/STTR small-business research awards from US health agencies, $10.4 million in total (2010 to 2016). NIH funding came from the National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1 million sold (2015).
Frequently asked questions about Sentien Biotechnologies
Where is Sentien Biotechnologies headquartered?
Sentien Biotechnologies, Inc. is headquartered in Medford, Massachusetts, United States.
What does Sentien Biotechnologies do?
Sentien Biotechnologies, Inc. is a biotechnology company.
Similar companies
- Travera, Inc.Medford, Massachusetts, United States
- Seventh Sense Biosystems, Inc.Medford, Massachusetts, United States
- Sofregen Medical Inc.Medford, Massachusetts, United States
- Greenlight Biosciences Inc.Medford, Massachusetts, United States
- Myrobalan Therapeutics Holding, Inc.Medford, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences